HNP Capital’s Medtronic MDT Stock Holding History

HNP Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-34,627	Closed	-$3.38M	–	225
2020 Q1	$3.38M	Buy	+34,627	New	+$3.68M	0.5%	45

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

HNP Capital's MDT Position: Q2 2020 in Review

HNP Capital sold out of Medtronic (MDT) in Q2 2020, closing a stake of 34,627 shares — an estimated $3.38M sold.

HNP Capital first reported a position in MDT in Q1 2020 and held it in 1 quarter. The position peaked at $3.38M in Q1 2020. 1,759 funds tracked by Wall St. Rank hold MDT as of Q2 2020.

HNP Capital reported no remaining Medtronic position as of Q2 2020 after selling out during the quarter.
HNP Capital sold 34,627 Medtronic shares in Q2 2020, an estimated $3.38M.
HNP Capital first reported a position in Medtronic in Q1 2020 and held it in 1 quarter.
HNP Capital's Medtronic position peaked at $3.38M in Q1 2020.
1,759 funds tracked by Wall St. Rank held Medtronic as of Q2 2020.

Based on HNP Capital's 13F filing for Q2 2020, filed 6 Jul 2020.